Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Summary of the Progress and Challenges in the Repurposing Kinase Inhibitors as Broad-Spectrum Antiviral Therapies
Immuno-Oncology Enhances Battlespace Awareness
Molecular Imaging Could Help Clinicians Accurately Select Patients for Treatment or Monitoring
For full access to this article login to GEN Select now.
Biomarker Analysis Makes Strides
- Personalized medicine made significant strides in 2011 with two new targeted cancer therapies, the FDA release of its companion diagnostics draft guidance, and routine clinical genotyping for some oncology applications. However, many challenges remain. An estimated 90% of currently marketed drugs are effective in only ~40% of patients annually, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.